You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Sale Disclosure
Kumar Neil · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$8.56K
Kumar Neil Chief Executive Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Aug 19, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 1 day later
BBIO daily price context
Close on/before transaction
$83.95
Aug 19, 2026
First close after public filing
$81.5
Aug 21, 2026
30-day return after filing
-18.31%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 100 shares @ $85.65
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000848
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$3.73M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 19, 2026 | $679.26K |
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 19, 2026 | $152.44K |
| Bridgebio Pharma, Inc. BBIO Current | Sale | Aug 19, 2026 | $8.56K |
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 18, 2026 | $100.44K |
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 18, 2026 | $1.42M |
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 18, 2026 | $1.21M |
| Bridgebio Pharma, Inc. BBIO | Sale | Aug 18, 2026 | $154.18K |